COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 165 filers reported holding COHERUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,479,272 | -41.3% | 395,527 | -33.0% | 0.00% | -100.0% |
Q2 2023 | $2,519,506 | -34.3% | 590,048 | +5.2% | 0.00% | 0.0% |
Q1 2023 | $3,836,556 | -16.4% | 560,900 | -3.2% | 0.00% | 0.0% |
Q4 2022 | $4,588,911 | -23.5% | 579,408 | -7.1% | 0.00% | 0.0% |
Q3 2022 | $5,996,000 | +43.0% | 623,891 | +7.7% | 0.00% | 0.0% |
Q2 2022 | $4,194,000 | -45.6% | 579,311 | -3.0% | 0.00% | 0.0% |
Q1 2022 | $7,708,000 | -31.9% | 597,045 | -15.8% | 0.00% | -50.0% |
Q4 2021 | $11,320,000 | -13.5% | 709,284 | -12.9% | 0.00% | -33.3% |
Q3 2021 | $13,086,000 | +19.6% | 814,371 | +2.9% | 0.00% | +50.0% |
Q2 2021 | $10,941,000 | -9.7% | 791,099 | -4.6% | 0.00% | 0.0% |
Q1 2021 | $12,120,000 | -15.4% | 829,625 | +0.7% | 0.00% | -33.3% |
Q4 2020 | $14,325,000 | +10.0% | 824,236 | +16.1% | 0.00% | 0.0% |
Q3 2020 | $13,024,000 | +3.4% | 710,166 | +0.7% | 0.00% | 0.0% |
Q2 2020 | $12,595,000 | +180.4% | 705,156 | +154.6% | 0.00% | +200.0% |
Q1 2020 | $4,492,000 | -10.4% | 276,946 | -0.5% | 0.00% | 0.0% |
Q4 2019 | $5,012,000 | -9.3% | 278,371 | +2.1% | 0.00% | -50.0% |
Q3 2019 | $5,525,000 | -20.8% | 272,739 | -13.6% | 0.00% | 0.0% |
Q2 2019 | $6,974,000 | +127.6% | 315,554 | +40.4% | 0.00% | +100.0% |
Q1 2019 | $3,064,000 | +52.2% | 224,698 | +1.0% | 0.00% | 0.0% |
Q4 2018 | $2,013,000 | -42.9% | 222,542 | +4.1% | 0.00% | 0.0% |
Q3 2018 | $3,527,000 | +35.2% | 213,776 | +14.8% | 0.00% | 0.0% |
Q2 2018 | $2,608,000 | +33.4% | 186,287 | +5.3% | 0.00% | 0.0% |
Q1 2018 | $1,955,000 | +33.9% | 176,988 | +6.7% | 0.00% | – |
Q4 2017 | $1,460,000 | -37.0% | 165,923 | -4.4% | 0.00% | -100.0% |
Q3 2017 | $2,317,000 | -4.9% | 173,541 | +2.2% | 0.00% | 0.0% |
Q2 2017 | $2,437,000 | -30.2% | 169,840 | +2.8% | 0.00% | 0.0% |
Q1 2017 | $3,492,000 | -11.4% | 165,140 | +17.9% | 0.00% | 0.0% |
Q4 2016 | $3,942,000 | +9.7% | 140,032 | +4.4% | 0.00% | 0.0% |
Q3 2016 | $3,592,000 | +54.3% | 134,127 | -2.7% | 0.00% | 0.0% |
Q2 2016 | $2,328,000 | +8.3% | 137,857 | +36.2% | 0.00% | 0.0% |
Q1 2016 | $2,149,000 | +12.9% | 101,207 | +22.0% | 0.00% | 0.0% |
Q4 2015 | $1,904,000 | +12.5% | 82,935 | -1.8% | 0.00% | 0.0% |
Q3 2015 | $1,693,000 | -38.3% | 84,482 | -11.0% | 0.00% | 0.0% |
Q2 2015 | $2,743,000 | +57.8% | 94,909 | +67.0% | 0.00% | – |
Q1 2015 | $1,738,000 | +536.6% | 56,825 | +239.2% | 0.00% | – |
Q4 2014 | $273,000 | – | 16,752 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 200,000 | $1,448,000 | 1.54% |
Tri Locum Partners LP | 376,486 | $2,726,000 | 1.12% |
Perceptive Advisors | 3,645,471 | $26,393,000 | 0.83% |
TANG CAPITAL MANAGEMENT LLC | 750,000 | $5,430,000 | 0.82% |
Bridge City Capital, LLC | 162,146 | $1,174,000 | 0.62% |
Knott David M Jr | 186,134 | $1,348,000 | 0.57% |
Aristotle Capital Boston, LLC | 2,322,168 | $16,812,000 | 0.50% |
Phocas Financial Corp. | 316,455 | $2,291,000 | 0.34% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $22,644,000 | 0.30% |
Temasek Holdings (Private) Ltd | 7,381,116 | $53,439,280 | 0.29% |